176 related articles for article (PubMed ID: 14618549)
21. Two cases of discontinuation syndrome following cessation of memantine.
Kwak YT; Han IW; Suk SH; Koo MS
Geriatr Gerontol Int; 2009 Jun; 9(2):203-5. PubMed ID: 19490142
[TBL] [Abstract][Full Text] [Related]
22. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
23. Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice.
Umegaki H; Itoh A; Suzuki Y; Nabeshima T
Int Psychogeriatr; 2008 Aug; 20(4):800-6. PubMed ID: 18341753
[TBL] [Abstract][Full Text] [Related]
24. Platelet neutralization test.
Radhakrishnan K
Methods Mol Biol; 2013; 992():349-51. PubMed ID: 23546727
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG
Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
[TBL] [Abstract][Full Text] [Related]
26. Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
O'Regan J; Lanctôt KL; Mazereeuw G; Herrmann N
J Clin Psychiatry; 2015 Nov; 76(11):e1424-31. PubMed ID: 26646039
[TBL] [Abstract][Full Text] [Related]
27. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study.
Ikeda M; Mori E; Kosaka K; Iseki E; Hashimoto M; Matsukawa N; Matsuo K; Nakagawa M;
Dement Geriatr Cogn Disord; 2013; 36(3-4):229-41. PubMed ID: 23949147
[TBL] [Abstract][Full Text] [Related]
28. Orthostatic tremor - a review.
Gerschlager W; Brown P
Handb Clin Neurol; 2011; 100():457-62. PubMed ID: 21496602
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of fanconi anemia by diepoxybutane analysis.
Auerbach AD
Curr Protoc Hum Genet; 2003 Jul; Chapter 8():Unit 8.7. PubMed ID: 18428345
[TBL] [Abstract][Full Text] [Related]
30. Medical marijuana and personal autonomy.
Boyd AJ
John Marshall Law Rev; 2004; 37(4):1253-88. PubMed ID: 16506343
[No Abstract] [Full Text] [Related]
31. Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients.
Shea C; MacKnight C; Rockwood K
Int Psychogeriatr; 1998 Sep; 10(3):229-38. PubMed ID: 9785144
[TBL] [Abstract][Full Text] [Related]
32. Alcohol and suicide.
Kendall RE
Subst Alcohol Actions Misuse; 1983; 4(2-3):121-7. PubMed ID: 6648755
[TBL] [Abstract][Full Text] [Related]
33. Effects of the 2011 duty hour reforms on interns and their patients: a prospective longitudinal cohort study.
Sen S; Kranzler HR; Didwania AK; Schwartz AC; Amarnath S; Kolars JC; Dalack GW; Nichols B; Guille C
JAMA Intern Med; 2013 Apr; 173(8):657-62; discussion 663. PubMed ID: 23529201
[TBL] [Abstract][Full Text] [Related]
34. The pharmacologic and clinical effects of medical cannabis.
Borgelt LM; Franson KL; Nussbaum AM; Wang GS
Pharmacotherapy; 2013 Feb; 33(2):195-209. PubMed ID: 23386598
[TBL] [Abstract][Full Text] [Related]
35. Cannabis and schizophrenia.
McLoughlin BC; Pushpa-Rajah JA; Gillies D; Rathbone J; Variend H; Kalakouti E; Kyprianou K
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004837. PubMed ID: 25314586
[TBL] [Abstract][Full Text] [Related]
36. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
Sznitman SR; Zolotov Y
Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
[TBL] [Abstract][Full Text] [Related]
37. Withdrawal syndrome after donepezil cessation in a patient with dementia.
Bidzan L; Bidzan M
Neurol Sci; 2012 Dec; 33(6):1459-61. PubMed ID: 22249402
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic benefits of cannabis: a patient survey.
Webb CW; Webb SM
Hawaii J Med Public Health; 2014 Apr; 73(4):109-11. PubMed ID: 24765558
[TBL] [Abstract][Full Text] [Related]
39. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
[TBL] [Abstract][Full Text] [Related]
40. Dementia with lewy bodies: diagnosis and management for primary care providers.
Zupancic M; Mahajan A; Handa K
Prim Care Companion CNS Disord; 2011; 13(5):. PubMed ID: 22295275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
